MEDLINE Status: In-Data-Review
Issn Electronic: 1097-6833
Chronic Pulmonary Insufficiency of Prematurity: Developing Optimal Endpoints for Drug Development.
Robin Steinhorn; Jonathan M Davis; Wolfgang Göpel; Alan Jobe; Steven Abman; Matthew Laughon; Eduardo Bancalari; Judy Aschner; Roberta Ballard; Anne Greenough; Linda Storari; Merran Thomson; Ronald L Ariagno; Laura Fabbri; Mark A Turner;
Author Information: Center for Hospital Based Specialties, Children's National Medical Center, Washington, DC. Electronic address: firstname.lastname@example.org.; The Floating Hospital for Children at Tufts Medical Center and the Tufts Clinical and Translational Science Institute, Boston, MA.; Department of Pediatrics, University of Lübeck, Lübeck, Germany.; Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.; Department of Pediatrics, Children's Hospital of Colorado, Aurora, CO.; Department of Pediatrics, The University of North Carolina at Chapel Hill, Chapel Hill, NC.; Department of Pediatrics, Miller School of Medicine, University of Miami, Jackson Memorial Hospital, Miami, FL.; Department of Pediatrics, Albert Einstein College of Medicine and Children's Hospital at Montefiore, Bronx, NY.; Department of Pediatrics, University of California, San Francisco, CA.; Neonatal Intensive Care Centre, King's College Hospital, London, UK.; Chiesi Farmaceutici SpA, Parma, Italy.; Hillingdon Hospital NHS Trust, Uxbridge, UK.; Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA.; Chiesi Farmaceutici SpA, Parma, Italy.; Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.